{"id":"NCT01887600","sponsor":"Astellas Pharma Europe B.V.","briefTitle":"Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis","officialTitle":"A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-09-03","primaryCompletion":"2017-11-01","completion":"2017-11-01","firstPosted":"2013-06-27","resultsPosted":"2020-12-17","lastUpdate":"2024-11-14"},"enrollment":594,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Anemia in Chronic Kidney Disease in Non-dialysis Patients"],"interventions":[{"type":"DRUG","name":"Roxadustat","otherNames":["ASP1517","FG-4592"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Roxadustat","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study was conducted to treat anemia in patients with chronic kidney disease. Anemia is a reduced number of red blood cells or hemoglobin. Hemoglobin is important for the transport of oxygen in your blood. The purpose of the study was to see if Roxadustat is both effective and safe as a treatment for anemia in patients with chronic kidney disease.","primaryOutcome":{"measure":"Percentage of Participants With a Hemoglobin (Hb) Response to Treatment at Two Consecutive Visits During the First 24 Weeks of Treatment Without Rescue Therapy Prior to Hb Response","timeFrame":"Baseline to week 24","effectByArm":[{"arm":"Roxadustat","deltaMin":79.2,"sd":null},{"arm":"Placebo","deltaMin":9.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":24},"locations":{"siteCount":138,"countries":["Belarus","Belgium","Bulgaria","Colombia","Dominican Republic","Estonia","Georgia","Greece","Guatemala","Hungary","Italy","Panama","Peru","Poland","Romania","Russia","Serbia","South Africa","Spain","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["36005278","34362786"],"seeAlso":["https://astellasclinicalstudyresults.com/study.aspx?ID=363"]},"adverseEventsSummary":{"seriousAny":{"events":241,"n":391},"commonTop":["Hypertension","Oedema peripheral","Hyperkalaemia","Anaemia","Viral upper respiratory tract infection"]}}